Is STERIS Plc Stock a Good Investment?

STERIS Plc Investment Advice

  STE
To provide specific investment advice or recommendations on STERIS plc stock, we recommend investors consider the following general factors when evaluating STERIS plc. This will help you to make an informed decision on whether to include STERIS Plc in one of your diversified portfolios:
  • Examine STERIS Plc's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research STERIS Plc's leadership team and their track record. Good management can help STERIS Plc navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact STERIS Plc's business and its evolving consumer preferences.
  • Compare STERIS Plc's performance and market position to its competitors. Analyze how STERIS Plc is positioned in terms of product offerings, innovation, and market share.
  • Check if STERIS Plc pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about STERIS Plc's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in STERIS plc stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if STERIS plc is a good investment.
 
Sell
 
Buy
Strong Buy
Macroaxis provides recommendation on STERIS plc to complement and cross-verify current analyst consensus on STERIS plc. Our trade recommendation engine determines the firm's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure STERIS plc is not overpriced, please validate all STERIS Plc fundamentals, including its number of shares shorted, total debt, beta, as well as the relationship between the gross profit and short ratio . Given that STERIS plc has a price to earning of 36.93 X, we advise you to double-check STERIS plc market performance and probability of bankruptcy to ensure the company can sustain itself next year given your current risk tolerance and investing horizon.

Market Performance

InsignificantDetails

Volatility

Very steadyDetails

Hype Condition

Low keyDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

Very LowDetails

Economic Sensitivity

Slowly supersedes the marketDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

Not AvailableDetails

Financial Strenth (F Score)

StrongDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails

Examine STERIS Plc Stock

Researching STERIS Plc's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 96.0% of the company shares are owned by institutional investors. The book value of STERIS Plc was at this time reported as 65.31. The company recorded earning per share (EPS) of 6.22. STERIS plc last dividend was issued on the 20th of February 2025. The entity had 2:1 split on the 25th of August 1998.
To determine if STERIS Plc is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding STERIS Plc's research are outlined below:
STERIS plc has a strong financial position based on the latest SEC filings
Over 96.0% of the company shares are owned by institutional investors
STERIS Plc uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in STERIS plc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to STERIS Plc's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
7th of February 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
8th of May 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of March 2023
Last Financial Announcement
View

STERIS Plc's market capitalization trends

The company currently falls under 'Large-Cap' category with a total capitalization of 21.98 B.

STERIS Plc's profitablity analysis

The company has Net Profit Margin of 0.09 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.18 %, which entails that for every 100 dollars of revenue, it generated $0.18 of operating income.
Determining STERIS Plc's profitability involves analyzing its financial statements and using various financial metrics to determine if STERIS Plc is a good buy. For example, gross profit margin measures STERIS Plc's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of STERIS Plc's profitability and make more informed investment decisions.
Please note, the presentation of STERIS Plc's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, STERIS Plc's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of STERIS Plc's management manipulating its earnings.

Basic technical analysis of STERIS Stock

As of the 25th of February, STERIS Plc has the risk adjusted performance of 0.0389, and Coefficient Of Variation of 2077.06. In connection with fundamental indicators, the technical analysis model makes it possible for you to check practical technical drivers of STERIS plc, as well as the relationship between them. Please validate STERIS plc information ratio, as well as the relationship between the potential upside and kurtosis to decide if STERIS Plc is priced adequately, providing market reflects its prevalent price of 223.79 per share. Given that STERIS plc has jensen alpha of 0.0426, we advise you to double-check STERIS plc's current market performance to make sure the company can sustain itself at some point in the future.

STERIS Plc's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific STERIS Plc insiders, such as employees or executives, is commonly permitted as long as it does not rely on STERIS Plc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases STERIS Plc insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

STERIS Plc's Outstanding Corporate Bonds

STERIS Plc issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. STERIS plc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most STERIS bonds can be classified according to their maturity, which is the date when STERIS plc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Understand STERIS Plc's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing STERIS Plc's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider STERIS Plc's intraday indicators

STERIS Plc intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of STERIS Plc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
STERIS Plc time-series forecasting models is one of many STERIS Plc's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary STERIS Plc's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

STERIS Stock media impact

Far too much social signal, news, headlines, and media speculation about STERIS Plc that are available to investors today. That information is available publicly through STERIS media outlets and privately through word of mouth or via STERIS internal channels. However, regardless of the origin, that massive amount of STERIS data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of STERIS Plc news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of STERIS Plc relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to STERIS Plc's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive STERIS Plc alpha.

STERIS Plc Corporate Directors

Richard BreedenIndependent DirectorProfile
Michael WoodIndependent DirectorProfile
Paul MartinIndependent DirectorProfile
Jacqueline KosecoffIndependent DirectorProfile
When determining whether STERIS plc is a strong investment it is important to analyze STERIS Plc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact STERIS Plc's future performance. For an informed investment choice regarding STERIS Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STERIS plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For information on how to trade STERIS Stock refer to our How to Trade STERIS Stock guide.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STERIS Plc. If investors know STERIS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STERIS Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of STERIS plc is measured differently than its book value, which is the value of STERIS that is recorded on the company's balance sheet. Investors also form their own opinion of STERIS Plc's value that differs from its market value or its book value, called intrinsic value, which is STERIS Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STERIS Plc's market value can be influenced by many factors that don't directly affect STERIS Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between STERIS Plc's value and its price, as these two are different measures arrived at by various means. Investors typically determine if STERIS Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STERIS Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.